Study on Purple Book of the United States and Discussion on the Necessity and Feasibility of Establishing Catalogue of Listed Biological Products in China

Yang Jianhong, Li Jie, Yang Liu, Shen Mengjuan, Zhang Xianglin

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (9) : 966-971.

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (9) : 966-971. DOI: 10.16153/j.1002-7777.2019.09.001

Study on Purple Book of the United States and Discussion on the Necessity and Feasibility of Establishing Catalogue of Listed Biological Products in China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 33(9): 966-971 https://doi.org/10.16153/j.1002-7777.2019.09.001

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉